OFFICIAL PUBLICATION OF

by its subsidiary APPco

High demand puts pressure on Shingrix supply chain

Nicholas O’Donoghue 02/02/2024

GSK expects to deliver 1.1 million doses of its shingles vaccine to the Commonwealth in the first half of 2024 Higher than anticipated demand for the National Immunisation Program (NIP) listed Shingrix vaccine is impacting the supply of the jab to pharmacies. Since the launch of the NIP Vaccination in Pharmacy (NIPVIP) program on 1

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘Consumer confusion, pharmacist frustration’ if current system continues

I welcome Mark's move, at least someone talks about it. But like any push at the forefront, it comes with…

Benjamyn Sung

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

High demand puts pressure on Shingrix supply chain

Previous Pharmacies claim over $227k through NIPVIP in January

Next John Coppock Pharmacist Wellbeing Award launched

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Pharmacies claim over $227k through NIPVIP in January

Next John Coppock Pharmacist Wellbeing Award launched

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.